Henry Schein (NASDAQ:HSIC) Shares Gap Down to $69.56

Shares of Henry Schein, Inc. (NASDAQ:HSIC) gapped down prior to trading on Tuesday . The stock had previously closed at $69.56, but opened at $65.00. Henry Schein shares last traded at $67.24, with a volume of 1,708,651 shares.

Wall Street Analyst Weigh In

Several research firms recently issued reports on HSIC. Baird R W raised shares of Henry Schein from a “hold” rating to a “strong-buy” rating in a research report on Monday, July 22nd. UBS Group reduced their target price on Henry Schein from $82.00 to $80.00 and set a “neutral” rating on the stock in a report on Wednesday, May 8th. Piper Sandler restated an “overweight” rating and set a $86.00 target price on shares of Henry Schein in a report on Friday, June 21st. Robert W. Baird raised shares of Henry Schein from a “neutral” rating to an “outperform” rating and increased their price objective for the stock from $81.00 to $92.00 in a report on Monday, July 22nd. Finally, Evercore ISI dropped their price objective on shares of Henry Schein from $75.00 to $72.00 and set an “in-line” rating for the company in a research report on Tuesday, July 9th. One investment analyst has rated the stock with a sell rating, six have assigned a hold rating, six have given a buy rating and one has given a strong buy rating to the stock. Based on data from MarketBeat.com, the stock has an average rating of “Moderate Buy” and an average price target of $81.67.

Henry Schein Stock Performance

The company has a quick ratio of 1.02, a current ratio of 1.75 and a debt-to-equity ratio of 0.47. The stock has a market cap of $8.34 billion, a P/E ratio of 21.89, a PEG ratio of 1.80 and a beta of 0.87. The stock has a fifty day simple moving average of $68.03 and a 200-day simple moving average of $71.78.

Henry Schein (NASDAQ:HSIC) last released its quarterly earnings data on Tuesday, August 6th. The company reported $1.23 earnings per share for the quarter, topping the consensus estimate of $1.22 by $0.01. Henry Schein had a net margin of 3.12% and a return on equity of 13.51%. The business had revenue of $3.10 billion for the quarter, compared to analyst estimates of $3.27 billion. During the same quarter last year, the firm earned $1.31 EPS. Henry Schein’s quarterly revenue was up .0% compared to the same quarter last year. Equities analysts expect that Henry Schein, Inc. will post 5.16 earnings per share for the current fiscal year.

Institutional Inflows and Outflows

Several hedge funds and other institutional investors have recently added to or reduced their stakes in the business. Swedbank AB bought a new position in Henry Schein in the first quarter valued at approximately $215,998,000. Boston Partners grew its holdings in shares of Henry Schein by 144.1% during the fourth quarter. Boston Partners now owns 2,637,429 shares of the company’s stock worth $199,393,000 after buying an additional 1,556,831 shares in the last quarter. Norges Bank acquired a new stake in Henry Schein in the 4th quarter valued at approximately $111,715,000. Nuance Investments LLC bought a new position in shares of Henry Schein during the 4th quarter worth approximately $103,446,000. Finally, Fiduciary Management Inc. WI lifted its position in shares of Henry Schein by 17.1% in the fourth quarter. Fiduciary Management Inc. WI now owns 2,284,337 shares of the company’s stock worth $172,947,000 after purchasing an additional 333,855 shares in the last quarter. 96.62% of the stock is currently owned by institutional investors.

Henry Schein Company Profile

Henry Schein, Inc provides health care products and services to dental practitioners, laboratories, physician practices, and ambulatory surgery centers, government, institutional health care clinics, and other alternate care clinics worldwide. It operates through two segments, Health Care Distribution, and Technology and Value-Added Services.